EGFR mutation of adenocarcinoma in congenital cystic adenomatoid malformation/congenital pulmonary airway malformation: Acase report

Japanese Journal of Clinical Oncology

Volumn 44, Issue 3, 2014, Pages 278-281

  Hasegawa, Mizue ^a   Sakai, Fumikazu ^b   Arimura, Ken ^a   Katsura, Hideki ^a   Koh, Eitetsu ^a   Sekine, Yasuo ^a   Hiroshima, Kenzo ^a  

^a Tokyo Women s Medical University   (Japan)

^b SAITAMA MEDICAL UNIVERSITY INTERNATIONAL MEDICAL CENTER   (Japan)

Author keywords

Congenital cystic adenomatoid malformation; EGFR genes; Lung cancer

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; K RAS PROTEIN; NAPSIN A; PROTEIN P53; THYROID TRANSCRIPTION FACTOR 1; UNCLASSIFIED DRUG; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE;

ADENOCARCINOMA; AGED; ARTICLE; ATYPICAL ADENOMATOUS HYPERPLASIA; BRONCHIOLOALVEOLAR ADENOCARCINOMA; CASE REPORT; CELL PROLIFERATION; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL CYSTIC ADENOMATOID MALFORMATION; CONGENITAL PULMONARY AIRWAY MALFORMATION; CYSTIC ADENOMATOID MALFORMATION; DISEASE ASSOCIATION; EGFR GENE; EPITHELIUM CELL; EXON; GENE MUTATION; HILOMEDIASTINAL LYMPHADENECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LOBECTOMY; LUNG NODULE; MALE; MALIGNANT TRANSFORMATION; MICROSCOPY; RESPIRATORY TRACT MALFORMATION; TREATMENT OUTCOME; CELL TRANSFORMATION; DRUG ANTAGONISM; EGFR GENES; GENETICS; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG TUMOR; MUTATION; PATHOLOGY; VERY ELDERLY;

CONGENITAL CYSTIC ADENOMATOID MALFORMATION; EGFR GENES; LUNG CANCER;

ADENOCARCINOMA; AGED, 80 AND OVER; CELL TRANSFORMATION, NEOPLASTIC; CYSTIC ADENOMATOID MALFORMATION OF LUNG, CONGENITAL; HUMANS; LUNG NEOPLASMS; MALE; MUTATION; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84899491378     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyt226     Document Type: Article

References (7)

1. Tomida S, Yatabe Y, Yanagawa K, Mitsudomi T, Takahashi T. Throwing new light of lung cancer pathogenesis: updates on three recent topics. Cancer Sci 2005;96:63-8.
2. Sakuma Y, Matsukuma S, Yoshihara M, et al. Distinctive evaluation of non-mucinous and mucinous subtypes of bronchioloalveolar carcinomas in EGFR and K-ras gene-mutation analysis for Japanese lung adenocarcinomas: confirmation of the correlation with histological subtypes and gene mutations. Am J Clin Pathol 2007;128:100-8.
3. MacSweeney F, Papagiannopoulos K, Goldstraw P, Sheppard MN, Corrin B, Nicholson AG. An assessment of the expanded classification of congenital cystic adenomatous malformations and their relationship to malignant transformation. Am J Surg Pathol 2003;27:1139-46.
4. Ribet ME, Copin M, Soots JG, Gosselin BH. Bronchioloalveolar carcinoma and congenital cystic adenomatoid malformation. Ann Thorac Surg 1995;60:1126-8.
5. West D, Nicholson AG, Colquhoun I, Pollock J. Bronchioloalveolar carcinoma in congenital cystic adenomatous malformation of the lung. Ann Thorac Surg 2007;83:687-9.
6. Stacher E, Ullmann R, Halbwedl I, et al. Atypical goblet cell hyperplasia in congenital cystic adenomatous malformation as a possible preneoplasia for pulmonary adenocarcinoma in childhood: a genetic analysis. Hum Pathol 2004;35:565-70.
7. Lanteuejoul S, Nicholson AG, Sartori G, et al. Mucinous cells in type 1 pulmonary congenital cystic adenomatoid malformation as mucinous bronchioloalveolar carcinoma precursors. Am J Surg Pathol 2007;31:961-9.